The U.S. Department of Health and Human Services (HHS) is set to revise the childhood vaccine schedule, aiming to reduce the number of recommended vaccinations. This change is expected to align the U.S. vaccination schedule more closely with that of other developed nations, particularly Denmark. The plan remains a work in progress and has faced delays, now anticipated to be announced in 2026.
Details of the Proposed Overhaul
Sources indicate that the new vaccine schedule may recommend fewer vaccinations for children. This overhaul follows President Donald Trump’s directive earlier this month to evaluate the current vaccination schedule with the potential aim of reducing the number of recommended shots.
- Current U.S. vaccination schedule includes numerous vaccines not recommended in Denmark, such as:
- Respiratory syncytial virus (RSV)
- Rotavirus
- Pneumococcal
- Hepatitis A
- Meningococcal
- Chickenpox
Denmark’s 2025 vaccine schedule has revealed a more selective vaccination approach. Medical experts have commented on the implications of this potential shift in policy.
Expert Opinions on Vaccination Changes
Critics, including Dr. Paul Offit and Dr. Peter Hotez, have raised concerns regarding the proposed changes and the implications of adopting a Danish-style vaccine schedule. They argue it could endanger children’s health by omitting critical vaccinations.
- Dr. Offit expressed skepticism, suggesting that Denmark’s reduced vaccine recommendations stem from financial decisions.
- Dr. Hotez labeled the proposal as unusual, warning it may lead to decreased vaccine availability in the U.S.
In contrast, Dr. Tracy Beth Hoeg noted the differences in healthcare systems between the U.S. and Denmark. She pointed out that Denmark’s approach is less politicized and differs significantly in terms of public health infrastructure.
Concerns About Disease Prevention
Dr. Adam Langer, an expert on hepatitis B, highlighted key differences that could affect health outcomes, including:
- Population size: Denmark has 6 million residents, while New York City alone has 8 million.
- Higher screening rates for hepatitis B among pregnant women in Denmark.
- Universal prenatal care available to all women in Denmark.
- Lack of a national health registry in the U.S., complicating follow-ups for at-risk infants.
Experts continue to debate the implications of adopting a vaccine schedule more akin to Denmark’s. The conversation surrounding this topic emphasizes the need for thorough evaluation of health strategies to ensure the safety and well-being of American children.
